Dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema.

@article{Medeiros2014DexamethasoneII,
  title={Dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema.},
  author={Marco Dutra Medeiros and Maurizio Postorino and Rafael Toledo Navarro and Jose Garcia-Arumi and Carlos Mateo and Borja Corc{\'o}stegui},
  journal={Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde},
  year={2014},
  volume={231 3},
  pages={
          141-6
        }
}
PURPOSE To report the 6-month anatomical and best-corrected visual acuity (BCVA) response after primary intravitreal dexamethasone implantation (Ozurdex®) in patients with refractory diabetic macular edema (DME). METHODS Retrospective review of the medical records of 58 patients with decreased visual acuity, due to refractory DME, who underwent a single injection of Ozurdex between November 2010 and January 2012, at the Instituto de Microcirurgia Ocular, Barcelona, Spain. RESULTS At… CONTINUE READING
BETA

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 36 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 23 REFERENCES

Dexa - methasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients

  • JE Chang-Lin, M Attar, +4 authors D Welty
  • Retina
  • 2011

Pharmacokinetics and pharmacodynamics of a sustainedrelease dexamethasone intravitreal implant

  • NV Saraiya, DA Goldstein
  • Invest Ophthalmol Vis Sci
  • 2011

Ran - domized , shamcontrolled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion

  • JA Haller, BD Kuppermann, +4 authors SM Whitcup
  • Ophthalmology
  • 2010

Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema

  • DS Boyer, D Faber, +5 authors SM Whitcup
  • Arch Ophthalmol
  • 2010

Safety and efficacy of ranibizumab in diabetic macular edema ( RESOLVE Study ) : a 12 - month , randomized , controlled , doublemasked , multi - center phase II study

  • MJ Elman, LP Aiello, +10 authors JK Sun
  • Diabetes Care
  • 2010

Similar Papers

Loading similar papers…